Hepion Pharmaceuticals, Inc. (HEPA)
NASDAQ: HEPA · Real-Time Price · USD
0.490
-0.040 (-7.56%)
Dec 20, 2024, 4:00 PM EST - Market closed
Hepion Pharmaceuticals Employees
Hepion Pharmaceuticals had 22 employees as of December 31, 2023. The number of employees decreased by 3 or -12.00% compared to the previous year.
Employees
22
Change (1Y)
-3
Growth (1Y)
-12.00%
Revenue / Employee
n/a
Profits / Employee
-$1,032,027
Market Cap
3.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China Pharma Holdings | 231 |
Check-Cap | 85 |
Nuwellis | 59 |
Sharps Technology | 57 |
Helius Medical Technologies | 22 |
Sonoma Pharmaceuticals | 10 |
180 Life Sciences | 4 |
Creative Medical Technology Holdings | 4 |
HEPA News
- 10 days ago - Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd. - GlobeNewsWire
- 16 days ago - Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson's Disease Study Group - GlobeNewsWire
- 19 days ago - Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B - GlobeNewsWire
- 3 months ago - Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger - GlobeNewsWire
- 5 months ago - Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer - Benzinga
- 8 months ago - Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH' Trial - GlobeNewsWire
- 10 months ago - Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell - GlobeNewsWire
- 11 months ago - Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds - GlobeNewsWire